April 27, 2005 — NanoString Technologies Inc., a Seattle developer of a biomolecular analysis platform, announced it has received an additional $3.8 million dollars from its Series A investors, bringing the total amount of capital raised to more than $8 million.
Last August the company reported that it had raised $4.3 million in early stage capital from investors Draper Fisher Jurvetson and OVP Venture Partners. The groups also held warrants to purchase a maximum of approximately $3.8 million, which they chose to exercise, according to a company release.